Dalteparin to improve haemostatic function in the diabetic foot

Members do not see these Ads. Sign Up.

Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.
Thromb Res. 2007 Feb 1;
Kalani M, Silveira A, Blombäck M, Apelqvist J, Eliasson B, Eriksson JW, Fagrell B, Torffvit O, Hamsten A, Jörneskog G

 

I am going to sound really cynical, bitter and twisted here, but while it is really fantastic that all these studies are being done to accelerate the healing of wounds in people who have diabetes, why aren't there more studies that aim at increasing foot screening of people with diabetes? How about ensuring that all those people with diabetes have a risk for amputation allocated to them and appropriate management implemented to PREVENT formation of ulceration - well, at least reduce incidence. Am I being too idealistic? Is this going to put people out of jobs, or lose pharmaceutical companies money? I am just a bit tired of these fantastic ideas to accelerate healing when we know the majority of these ulcers are preventable and we are not doing enough to prevent. In addition, if these ulcers are identified early enough, appropriate pressure redistribution (if a significant arterial process is not present) is able to heal most cases quickly - but it means identifying the problem early - another area that needs work.

An added peeve is that we, in our clinic, never get our hands on these fantastic super new products - they cost too much!

Am I the only one who thinks this way?!

Sorry - Monday morning irritation!